Scialabba, C.; Craparo, E.F.; Bonsignore, S.; Cabibbo, M.; Cavallaro, G.
Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation. Pharmaceutics 2024, 16, 1454.
https://doi.org/10.3390/pharmaceutics16111454
AMA Style
Scialabba C, Craparo EF, Bonsignore S, Cabibbo M, Cavallaro G.
Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation. Pharmaceutics. 2024; 16(11):1454.
https://doi.org/10.3390/pharmaceutics16111454
Chicago/Turabian Style
Scialabba, Cinzia, Emanuela Fabiola Craparo, Sofia Bonsignore, Marta Cabibbo, and Gennara Cavallaro.
2024. "Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation" Pharmaceutics 16, no. 11: 1454.
https://doi.org/10.3390/pharmaceutics16111454
APA Style
Scialabba, C., Craparo, E. F., Bonsignore, S., Cabibbo, M., & Cavallaro, G.
(2024). Lipid–Polymer Hybrid Nanoparticles in Microparticle-Based Powder: Evaluating the Potential of Methylprednisolone Delivery for Future Lung Disease Treatment via Inhalation. Pharmaceutics, 16(11), 1454.
https://doi.org/10.3390/pharmaceutics16111454
